GlobalData has reviewed the location of global clinical trials in the immuno-oncology (IO) space that were initiated between 2008 and 2017. During this period, single-country trials greatly outnumbered multinational IO clinical trials. Their relative contribution fluctuated between 72% and 87%, as shown in Figure 1. Over the 10-year period, there were 3.9 times as many single-country trials as multinational trials, and 95% of non-industry trials were conducted in single countries. A relatively high number of multinational trials were seen in 2014 and 2015, which is consistent with the higher number of industry-sponsored trials in these two years.
Figure 1: Single-country and multinational io clinical trials
Go deeper with GlobalData
| Source: GlobalData © GlobalData |
Related Reports
- GlobalData (2018). Clinical Trials: Global Trends in Immuno-oncology. A 10-Year Retrospective, 2008–2017. Report Code: GDHC1699EI.
- GlobalData (2017). PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities, August 2017, Report Code: GDHC009PFR.
For more insight and data, visit the GlobalData Report Store – Pharmaceutical Technology is part of GlobalData Plc.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
